Heart drug study for diabetes stopped early: what happened?
Disease control
Terminated
This study tested a drug called pemafibrate in over 10,000 people with type 2 diabetes and high triglycerides. The goal was to see if it could prevent heart attacks, strokes, or heart-related death. The study was stopped early, and results are being analyzed.
Phase: PHASE3 • Sponsor: Kowa Research Institute, Inc. • Aim: Disease control
Last updated May 08, 2026 12:01 UTC